Navigation Links
Immunotherapy in Oncology Drug Pipeline Update 2011
Date:9/7/2011

ts

Summary field of developmental projects for the drug, including indication, developmental stage and status.

Example:

Cancer, myeloma – Phase II Clinical Trial – Active

Cancer, prostate – Phase III Clinical Trial – Ceased

Drug Description

Short introduction to drug

Compound Data

Compound type, Chemical name, CAS Number and molecular weight

Patent Data

Available patent information related to the drug is presented here.

Business & Markets

Collaborations and deals

Approvals and submissions

Analyst comments

Phase III Data

Available Phase III development data, developmental history and scientific data.

Phase II Data

Available Phase II development data, developmental history and scientific data.

Phase I Data

Available Phase I development data, developmental history and scientific data.

Preclinical Data

Available preclinical development data, developmental history and scientific data.

Licensing Information

Availability for licensing

Application Features

Use 13 different parameters, available in drop-down menus, to find and sort among drugs

- Drug status

- Clinical Trial Status

- Principle Investigator

- Partners

- Indication

- Developmental Stage

- Compound Type

- Mechanism

- Target

- Molecular Function of Target

- Target Localization

- Targeted Pathways

- Free text search of entire drug profile contents

Direct linkage from inside the application to related internet resources

- Drug data is linked to search engines like Google and PubMed

- Drug target data is linked directly to BioCarta, Human Protein Atlas, KEGG, and NetPath

- Direct links to company web pages of principal investigators

Dynamic Report Generator

Our dynamic report ge
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
2. Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
3. New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
4. Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients
5. Landmark Study Demonstrates Potential of Radioimmunotherapy for Treatment of Indolent B-Cell Non-Hodgkins Lymphoma
6. Prostate Cancer Immunotherapy Significantly Prolongs Survival in Men With Advanced Prostate Cancer
7. Octapharma Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders and Critical Care
8. Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies
9. Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy
10. Results From Argos Therapeutics Arcelis™ Immunotherapy Phase 2 Study for Treatment of Renal Cell Carcinoma (RCC) Accepted for Poster Presentation at Ninth International Kidney Cancer Symposium
11. Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 2014 This BCC Research report discusses the medical device ... growth and size, and opportunities for different devices and regions. ... Patent analysis in the report focuses on technological trends in ... Europe and Japan . ... the global medical device technologies market. - Analyze market structure, ...
(Date:9/18/2014)...  Iliad Neurosciences, Inc., a company focused on the ... Spectrum Disorders (ASD) announced today that it has entered ... for The State University of New York. ... to identify an abnormality in folate transport to the ... expected to be available for research use by physicians ...
(Date:9/18/2014)... , September 18, 2014 ... audience, has updated the incredibly successful Serialisation Countdown calendar ... interactive PDF, available at pharmaserialisation.com shows the ... which they will be coming into force. ... longer a matter of "if", but "when" they will ...
Breaking Medicine Technology:Medical Devices: Technologies and Global Markets 2Medical Devices: Technologies and Global Markets 3Medical Devices: Technologies and Global Markets 4Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 3Pharma IQ Displays Worldwide Serialisation Deadlines in their 2014 - 2018 Countdown Calendar 2
... MADISON, N.J., Jan. 6, 2012 Quest Diagnostics Incorporated ... of diagnostic testing, information and services, announced today the ... Health System to acquire S.E.D. Medical Laboratories. Under the ... assets of S.E.D. Medical Laboratories and will manage in-patient ...
... 2012 In preparation for meetings starting Monday, ... scheduled for 10:00 a.m. Thursday, January 12 at ... Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR ) ... the fourth quarter 2011:       -Approximately 935-950 ...
Cached Medicine Technology:Quest Diagnostics Completes Acquisition of S.E.D. Medical Laboratories 2Questcor Pharmaceuticals Reports Strong Finish to 2011 2Questcor Pharmaceuticals Reports Strong Finish to 2011 3Questcor Pharmaceuticals Reports Strong Finish to 2011 4Questcor Pharmaceuticals Reports Strong Finish to 2011 5Questcor Pharmaceuticals Reports Strong Finish to 2011 6
(Date:9/18/2014)... Georgia (PRWEB) September 18, 2014 Technology ... the winners of its 2nd TAG Social Savvy Awards ... Junior Achievement’s Chick-fil-A Foundation Discovery Center in Downtown Atlanta. ... media. , Turner Sports was honored with the ... This year’s event also recognized innovators in 6 other ...
(Date:9/18/2014)... Researchers are trying to learn more about a condition ... in young athletes. In people with sickle cell ... muscle breakdown that can lead to kidney damage and ... players in the United States collapsed and died during ... trait. "More student-athletes with sickle cell trait have ...
(Date:9/18/2014)... NC (PRWEB) September 18, 2014 October ... also Domestic Violence Awareness Month. And the Centers for ... tells a scary story. , According to the CDC ... fourth of men in the U.S. experience some form ... intimate relationship. The same survey shows that about half ...
(Date:9/18/2014)... September 18, 2014 Fall is here, and ... bike is here to stay. Just as the temperature ... up, says Bikesdirect.com . Women across America are discovering ... calls a city bike. , Windsor Bicycles USA says, "City ... are higher than the typical road bike, and the seat ...
(Date:9/18/2014)... technology has shed new light on how certain symptoms ... according to a new study. PTSD is ... range of debilitating symptoms, such as flashbacks to a ... and avoiding certain situation and people, according to background ... opioid receptor in the brain linked to emotion that ...
Breaking Medicine News(10 mins):Health News:Winners Honored at 2014 TAG Social Savvy Awards 2Health News:Winners Honored at 2014 TAG Social Savvy Awards 3Health News:Scientists Studying Sickle Cell Trait 2Health News:What you should know about domestic violence 2Health News:What you should know about domestic violence 3Health News:What you should know about domestic violence 4Health News:What you should know about domestic violence 5Health News:City Bikes Become a Must-have for Women This Fall, Says Bikesdirect.com 2Health News:Research Shows Possible Neurological Patterns for PTSD Symptoms 2Health News:Research Shows Possible Neurological Patterns for PTSD Symptoms 3
... WASHINGTON, DC) The Society for Cardiovascular Angiography and ... announced today that they will hold a unified interventional ... meeting will be known as The SCAI Annual Scientific ... be held concomitantly with the ACC Annual Scientific Session. ...
... men who have sex with men (MSM) in New York City, ... among MSM under age 30 have increased by 33% during the ... to almost 500 in 2006. New diagnoses have doubled among MSM ... under-30 group now accounts for 44% of all new diagnoses among ...
... Sept. 11 The Department of,Public Welfare today ... system whose personal information may have been contained,on ... office building in Harrisburg., The burglary remains ... the information on the stolen computers has been ...
... PT. RICHMOND, Calif., Sept. 11 Transcept,Pharmaceuticals, Inc., ... from proven CNS drugs, today announced,that Glenn A. ... present at the UBS 2007 Global Life Sciences ... Tuesday, September 25, 2007 at 4:00 p.m. ET. ...
... Is the Most Comprehensive Ever, NEW YORK, ... research,-- the most comprehensive ever conducted -- once ... safe, even among its heaviest users. The ... Use,Levels, Regulations, and Toxicological and Epidemiological Studies,",published in ...
... opportunities for immigrants to obtain legal residency and citizenship ... access to health care, according to an article published ... Affairs. , Immigrants now make up 12 percent ... lead author of the article and a policy researcher ...
Cached Medicine News:Health News:SCAI and ACC announce new interventional cardiology meeting 2Health News:New HIV diagnoses rising in New York City among young men who have sex with men 2Health News:New HIV diagnoses rising in New York City among young men who have sex with men 3Health News:New HIV diagnoses rising in New York City among young men who have sex with men 4Health News:PA Department of Public Welfare Begins Outreach to Medical Assistance Consumers Following Burglary at State Office Building 2Health News:New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users 2Health News:New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users 3Health News:RAND researchers offer options to improve immigrant health care quality, access 2
The MULTI-LINK RX PENTA Coronary Stent Systems with new ACCESS-LINK Stent Design are indicated for improving coronary luminal diameter....
Now available in 2.75-mm diameters, the S660 small vessel coronary stent expands your treatment options for accurate sizing and precision stenting....
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
... EVS has an ergonomic stapler ... mechanism which requires a single ... locks onto the target vessel ... site before, during and after ...
Medicine Products: